Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Vestibular SchwannomaFacial Nerve Paralysis
Interventions
DRUG

Steroids therapy

Methylprednisolone sodium succinate 80 mg powder dissolved in 100 mL of sodium chloride solution (intravenous infusion, once daily) from the day of surgery to day 3, followed by 20 mg of prednisone acetate (oral intake, once daily) from day 4 to day 10.

DRUG

Placebo

Methylprednisolone sodium succinate placebo powder dissolved in 100 mL of sodium chloride solution (intravenous infusion, once daily) from the day of surgery to day 3, followed by prednisone acetate placebo (oral intake, once daily) from day 4 to day 10.

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER